-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.O1.6 613. Acute Myeloid Leukemia: Clinical Studies: Advances in Therapy

Acute Myeloid Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 7:00 AM-8:30 AM
W110, Level 1 (Orange County Convention Center)
Moderators:
Margaret O'Donnell, MD, City of Hope and Felicetto Ferrara, MD, Cardarelli Hospital

Disclosures:
No relevant conflicts of interest to declare.
7:00 AM

Lionel Ades, MD, PhD1, Xavier Thomas, MD, PhD2, Agnes Guerci-Bresler, MD3*, Raffoux Emmanuel4*, Olivier Spertini5, Norbert Vey6, Thierry Lamy, MD, PhD7, Christian Récher, MD PhD8, Arnaud Pigneux9*, Dominique Bordessoule10, Eric Deconinck11, Claude Gardin12*, Olivier Tournilhac13*, Jean-Francois Lambert, MD14, Patrice Chevallier, MD, PhD15*, Stephane de Botton16*, Julie Lejeune17*, Hervé Dombret18, Sylvie Chevret19* and Pierre Fenaux, MD, PhD20

1Service d’Hématologie Séniors, St Louis hospital, University Paris 7, Paris, France
2CHU, Lyon, France
3Hematology department, Hôpital d'Adultes du Brabois, CHU Nancy, Nancy, France
4Hematology Department, Saint Louis Hospital, Paris, France
5Hematology, CHUV, Lausanne, Switzerland
6Hematology, Institut Paoli-Calmettes, Marseille, France
7Haematology, CHU Pontchaillou, Rennes, France
8Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
9Hematology, Hôpital Haut Lêveque, Pessac, France
10Hematologie Clinique, CHU de Limoges, Limoges, France
11Hematology, INSERM UMR1098 - CHU Jean Minjoz, Besancon, France
12Hematology, Hopital Avicenne, Bobigny, France
13CHU Clermont Ferrand, Clermont Ferrand Cedex 1, France
14Hospital of Nyon, Nyon, Switzerland
15Department of Hematology, Nantes University Hospital, Nantes, France
16Institut Gustave Roussy, Villejuif, France
17Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France
18Hematology, Hôpital Saint-Louis, Paris, France
19Biostatistics department, Hôpital Saint-Louis, Paris, France
20Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

7:15 AM

Michael R. Savona, MD1, Steven D. Gore, MD2, Kathryn S. Kolibaba3, Stacey M. Ukrainskyj, BSN4*, Keshava Kumar, PhD4*, Qian Dong, MS4*, Joel Hetzer, PhD4*, Barry Skikne, MD4 and Guillermo Garcia-Manero, MD5

1Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
2Yale Cancer Center, New Haven, CT
3US Oncology Research, The Woodlands, TX
4Celgene Corporation, Summit, NJ
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

7:30 AM

Guillermo Garcia-Manero, MD1, Ehab Atallah, MD2, Samer K Khaled, MD3, Martha Arellano4, Mrinal M Patnaik, MBBS5, Todd A Butler6*, Carla Ashby6* and Bruno C. Medeiros, MD7

1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
2Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
3City of Hope, Duarte, CA
4Hematology/Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
5Division of Hematology, Mayo Clinic, Rochester, MN
6MEI Pharma, Inc., San Diego, CA
7Division of Hematology/Oncology, Stanford Comprehensive Cancer Center, Stanford Univ., Stanford, CA

7:45 AM

Amir T. Fathi, MD1, Harry P. Erba, MD, PhD2, Jeffrey E Lancet, M.D.3, Eytan M Stein, M.D.4, Roland B. Walter, MD, PhD, MS5, Daniel J. DeAngelo, MD, PhD6, Stefan Faderl, MD7*, Anand P Jillella, MD8, Farhad Ravandi, MD9, Anjali S. Advani, MD10, Dale Bixby, MD, PhD11, Tibor J. Kovacsovics, MD12, Megan M. O'Meara, MD13, Dana A. Kennedy, PharmD14 and Anthony S. Stein, MD15

1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
2Internal Medicine, Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
4Memorial Sloan Kettering Cancer Center, New York, NY
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
7John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
8Winship Cancer Institute of Emory University, Atlanta, GA
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
10Leukemia Program, Cleveland Clinic, Cleveland, OH
11Univ. of Michigan Comprehensive Cancer Ctr., Ann Arbor, MI
12Huntsman Cancer Institute - University of Utah, Salt Lake City, UT
13Clinical Development, Seattle Genetics, Inc., Bothell, WA
14Clinical, Seattle Genetics, Inc., Bothell, WA
15Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

8:00 AM

Mei Guo1*, Jianyong Li, MD, PhD2, Zheng Dong3*, Li Liu4*, Xuliang Shen, MD5*, Xinrong Zhan6*, Depei Wu, MD7*, Linhua Yang8*, Yangyi Bao9*, Xuzhang Lu10*, Changlin Yu11*, Jianhui Qiao1*, Kaixun Hu1*, Wanjun SUN12*, Hongli Zuo1*, Yajing Huang1*, Junxiao Qiao13*, Bo CAI1*, Zhiqing LIU1*, Tieqiang LIU1*, Bo Yao1*, Hongxia Zhao12*, Juan WANG14*, Qiyun SUN1* and Huisheng Ai, MD15*

1Affiliated Hospital of Academy of Military Medical Sciences, BEIJING, China
2Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
3Affiliated Hospital of Academy of Military Medical Sciences, beijig, China
4Tangdu Hospital, Xian, China
5Heping Hospital of Changzhi Medical College, Changzhi, China
6Central Hospital of Xinxiang City, XINXIANG, China
7Department of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China
8The Second Hospital of Shanxi Medical University, Taiyuan, China
9The Third Affiliated Hospital of Anhui Medical University, hefei, China
10Changzhou No2 people's hospital, Changzhou, China
11Affiliated Hospital of the Academy of Military Medical Sciences, Beijing, China
12Second Artillery General Hospital, BEIJING, China
13Second Artillery General Hospital, BEIJNG, China
14Central Hospital of Cangzhou City, CANGZHOU, China
15Department of Hematology and Transplantation, Affiliated Hospital of Academy of Military Medical Sciences, BEIJING, China

8:15 AM

Eve Poret1*, Chrystelle Vidal2*, Yohan Desbrosses3*, Fanny Angelot Delettre1*, Maider Pagadoy2*, Aurore Pugin4*, Louis Benazet2*, Franck Leroux2*, Elise Robert5*, Delphine Binda2*, Sabeha Biichle6*, Anne Roggy, PhD STUDENT7*, Laure Philippe, medical student8*, Berengere Gruson9*, Anne-Claire Gac10*, Michel Maigre11*, Denis Caillot12*, Remy Gressin, MD13, Pascal Turlure, MD14*, Anne-Sophie Michallet, MD15*, Lila Gilis16*, Veronique Dorvaux17*, Yazid Arkam18*, Caroline Bonmati, MD19*, Pierre Péterlin20*, Pierre-Simon Rohrlich, MD, PhD21*, Thorsten Braun, MD, PhD22*, jean-Valere Malfuson23*, Didier Bouscary, MD PhD24*, Eric Pujade-Lauraine25*, Felipe Suarez, MD, PhD26, Carole Soussain, MD27, Etienne Lengliné, MD28*, Mathieu Puyade, md29*, Tony Marchand, MD30*, Denis Guyotat31*, Bruno Lioure, MD32*, Christian Recher, MD33, Damien Roos-Weil34*, Fabrice Jardin35*, Jean-Pierre Marolleau36, Bernard Drenou, MD37*, Bernard Bonnotte, MD, PhD38*, Sophie Dalac39*, Philippe Saas, PhD40, Francine Garnache Ottou, PhD41* and Eric Deconinck42

1EFS BFC, INSERM UMR1098, Besançon cedex, France
2Inserm CIC1431, CHRU de Besançon, Besançon cedex, France
3CHU Jean Minjoz, Besançon, France
4CHRU de Besançon, Inserm CIC1431, Besançon cedex, France
5CHRU de Besançon, Besançon, France
6INSERM UMR 1098/Université Bourgogne Franche-Comté/EFS BFC, Besancon, France
7INSERM UMR 1098/Université Bourgogne Franche-Comté/ EFS BFC, Besançon cedex, France
8CHU Jean Minjoz, hematology, INSERM UMR 1098/Université Bourgogne Franche-Comté/ EFS BFC, Besançon, France
9Hopital d'Amiens, Amiens, France
10Hopital de Caen, Caen, France
11Hopital de Chartres, Chartres, France
12Hôpital du Bocage, Dijon, France
13Service d'hématologie clinique, CHU Grenoble, Grenoble, France
14CHU de Limoges, Limoges, France
15CHU Lyon Sud-Pierre Bénite, Pierre-Benite, France
16Hopital Lyon Sud, Lyon, France
17Medecine Interne, Hopital Notre Dame de Bon Secours, Metz-Thionville, France
18Hopital de Mulhouse, Mulhouse, France
19CHU Nancy, Nancy, France
20CHU Nantes, Nantes, France
21CHU de Nice, Nice, France
22Clinical Hematology, CHU Avicenne, Bobigny, France
23university hospital, clamart, France
24CHU Cochin, Paris, France
25Hospital Hotel Dieu, Paris, France
26Hematologie, Hopital Necker, Assistance Publique-Hopitaux de Paris French Ref. Ctr. for Prima, Paris, France
27Dept. of Hematologie, Centre René Huguenin, Saint-Cloud, France
28Hospital Saint Louis, Paris, France
29university hospital, poitiers, France
30Department of Hematology, Centre Hospitalier Universitaire de Rennes, Rennes, France
31Hospital Saint Etienne, Saint Etienne, France
32Department of Hematology and Oncology, CHU Hautepierre, Strasbourg, France
33Hôpital Purpan-CHU de Toulouse, Toulouse, France
34Hopital Pitie-Salpetriere, Paris, France
35Centre Henri Becquerel, Rouen, France
36Hematology, Hôpital Sud, Amiens, France
37CH MULHOUSE, MULHOUSE, France
38Department of Internal Medicine and Clinical Immunology, University Hospital, Dijon, France
39Hospiatl Dijon, Dijon, France
40EFS BFC, INSERM UMR 1098/Université Bourgogne Franche-Comté/ EFS BFC/LabEx lispSTIC, Besancon, France
41EFS BFC, Inserm UMR1098, University hospital Besancon, University Franche Comte, Besancon, France
42Hematology, INSERM UMR1098 - CHU Jean Minjoz, Besancon, France

*signifies non-member of ASH